• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫球蛋白G中寡糖-蛋白质相互作用的变化决定了位点特异性糖基化谱,并调节Fc寡糖的动态运动。

Variations in oligosaccharide-protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides.

作者信息

Wormald M R, Rudd P M, Harvey D J, Chang S C, Scragg I G, Dwek R A

机构信息

Oxford Glycobiology Institute, Department of Biochemistry, University of Oxford, U.K.

出版信息

Biochemistry. 1997 Feb 11;36(6):1370-80. doi: 10.1021/bi9621472.

DOI:10.1021/bi9621472
PMID:9063885
Abstract

Glycoproteins, such as immunoglobulin G (IgG), consist of an ensemble of glycosylated variants, or glycoforms, which have different oligosaccharides attached to a common peptide. Alterations in the normal glycoform populations of IgG are associated with certain disease states, notably rheumatoid arthritis and its remission during pregnancy. In this paper, we show that two sets of IgG Fc glycoforms have quite different physical properties. The first set has 1,6 arm terminal galactose residues which interact with the protein, resulting in glycan binding to the protein surface, in agreement with the crystal structure. In contrast, the second set of glycoforms which lack galactose does not bind to the protein surface. Recently developed HPLC techniques combined with enzymatic digestion and mass spectrometry have been used to assign the glycan structures on IgG, Fab, and Fc. Comparison of Fab with Fc shows that glycosylation is site-specific. Two major glycan structures are present on Fab (fucosylated digalacto-bianntenary with and without bisect) and three on Fc (fucosylated agalacto-, 1,6 arm monogalacto-, and digalacto-bianntenary). In comparison to Fab, Fc glycans contain (i) lower levels of bisecting GlcNAc, (ii) lower levels of galactose, (iii) higher than expected levels of 1,6 arm galactose relative to 1,3 arm, and (iv) no 1,6 arm sialylation. We interpret these differences to indicate a role for both the protein quaternary structure and specific protein-glycan interactions in determining the glycoform populations. NMR relaxation measurements have been used to probe the mobility of the glycans in the Fc. By comparing two samples with different glycoform populations, we conclude that this mobility is dependent on the primary sequence of the glycan. Glycans carrying a galactose residue on the 1,6 arm have relaxation properties very similar to those of the peptide backbone and thus do not have independent motion. Glycans lacking galactose have relaxation rates 30 times slower than that of the peptide and thus a higher degree of mobility. These agalactosyl glycans do not interact with the protein, resulting in exposure of previously covered regions of the peptide surface and making the glycan more accessible. This implies that at the early stages of glycan processing the Fc glycans are mobile and only partially protected by the protein quaternary structure. Immobilization of the glycans occurs as a consequence of addition of galactose to the 1,6 arm and results in increased protection.

摘要

糖蛋白,如免疫球蛋白G(IgG),由一组糖基化变体或糖型组成,这些变体或糖型具有连接到共同肽段上的不同寡糖。IgG正常糖型群体的改变与某些疾病状态相关,特别是类风湿性关节炎及其在怀孕期间的缓解。在本文中,我们表明两组IgG Fc糖型具有截然不同的物理性质。第一组在1,6臂末端有半乳糖残基,其与蛋白质相互作用,导致聚糖结合到蛋白质表面,这与晶体结构一致。相比之下,第二组缺乏半乳糖的糖型不与蛋白质表面结合。最近开发的HPLC技术与酶消化和质谱联用,已用于确定IgG、Fab和Fc上的聚糖结构。Fab与Fc的比较表明糖基化是位点特异性的。Fab上存在两种主要的聚糖结构(有和没有平分型的岩藻糖基化二半乳糖-双天线型),Fc上有三种(岩藻糖基化无半乳糖型、1,6臂单半乳糖型和二半乳糖-双天线型)。与Fab相比,Fc聚糖含有:(i)较低水平的平分型N-乙酰葡糖胺;(ii)较低水平的半乳糖;(iii)相对于1,3臂,1,6臂半乳糖水平高于预期;(iv)没有1,6臂唾液酸化。我们将这些差异解释为表明蛋白质四级结构和特定的蛋白质-聚糖相互作用在决定糖型群体中都起作用。NMR弛豫测量已用于探测Fc中聚糖的流动性。通过比较具有不同糖型群体的两个样品,我们得出结论,这种流动性取决于聚糖的一级序列。在1,6臂上带有半乳糖残基的聚糖具有与肽主链非常相似的弛豫性质,因此没有独立的运动。缺乏半乳糖的聚糖弛豫速率比肽慢30倍,因此具有更高程度的流动性。这些无糖基化聚糖不与蛋白质相互作用,导致肽表面先前被覆盖区域的暴露,使聚糖更容易接近。这意味着在聚糖加工的早期阶段,Fc聚糖是可移动的,并且仅部分地受到蛋白质四级结构的保护。由于在1,6臂上添加了半乳糖,聚糖发生固定化,导致保护增加。

相似文献

1
Variations in oligosaccharide-protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides.免疫球蛋白G中寡糖-蛋白质相互作用的变化决定了位点特异性糖基化谱,并调节Fc寡糖的动态运动。
Biochemistry. 1997 Feb 11;36(6):1370-80. doi: 10.1021/bi9621472.
2
Glycobiology: 'the function of sugar in the IgG molecule'.糖生物学:“糖在免疫球蛋白分子中的功能”
J Anat. 1995 Oct;187 ( Pt 2)(Pt 2):279-92.
3
Contrasting glycosylation profiles between Fab and Fc of a human IgG protein studied by electrospray ionization mass spectrometry.通过电喷雾电离质谱法研究人IgG蛋白的Fab和Fc之间的糖基化谱差异。
J Immunol Methods. 2007 Sep 30;326(1-2):116-26. doi: 10.1016/j.jim.2007.07.014. Epub 2007 Aug 8.
4
Site-specific N-glycosylation of chicken serum IgG.鸡血清IgG的位点特异性N-糖基化
Glycobiology. 2004 Mar;14(3):275-92. doi: 10.1093/glycob/cwh031. Epub 2003 Dec 23.
5
Fc glycans terminated with N-acetylglucosamine residues increase antibody resistance to papain.以N-乙酰葡糖胺残基结尾的Fc聚糖可增强抗体对木瓜蛋白酶的抗性。
Biotechnol Prog. 2007 Jul-Aug;23(4):964-71. doi: 10.1021/bp070118k. Epub 2007 Jun 16.
6
Quantitative glycan profiling of normal human plasma derived immunoglobulin and its fragments Fab and Fc.正常人类血浆来源免疫球蛋白及其片段 Fab 和 Fc 的定量糖基化分析。
J Immunol Methods. 2012 Aug 31;382(1-2):167-76. doi: 10.1016/j.jim.2012.05.022. Epub 2012 Jun 6.
7
Site-specific glycosylation analysis of the bovine lysosomal alpha-mannosidase.牛溶酶体α-甘露糖苷酶的位点特异性糖基化分析
Glycobiology. 2006 May;16(5):440-61. doi: 10.1093/glycob/cwj081. Epub 2006 Jan 31.
8
Altered O-glycosylation and sulfation of airway mucins associated with cystic fibrosis.与囊性纤维化相关的气道黏蛋白O-糖基化和硫酸化改变。
Glycobiology. 2005 Aug;15(8):747-75. doi: 10.1093/glycob/cwi061. Epub 2005 Apr 15.
9
IgG fc N-glycosylation changes in Lambert-Eaton myasthenic syndrome and myasthenia gravis.Lambert-Eaton 肌无力综合征和重症肌无力中的 IgG fc N-糖基化改变。
J Proteome Res. 2011 Jan 7;10(1):143-52. doi: 10.1021/pr1004373. Epub 2010 Jul 30.
10
Site-specific N-glycan characterization of human complement factor H.人补体因子H的位点特异性N-聚糖表征
Glycobiology. 2007 Sep;17(9):932-44. doi: 10.1093/glycob/cwm060. Epub 2007 Jun 25.

引用本文的文献

1
Role of Antibody Glycosylation in Health, Disease, and Therapy.抗体糖基化在健康、疾病及治疗中的作用。
Handb Exp Pharmacol. 2025;288:189-209. doi: 10.1007/164_2025_744.
2
Introduction of a human- and keyboard-friendly N-glycan nomenclature.一种对人类和键盘友好的N-聚糖命名法介绍。
Beilstein J Org Chem. 2024 Mar 15;20:607-620. doi: 10.3762/bjoc.20.53. eCollection 2024.
3
Immunomodulation of Antibody Glycosylation through the Placental Transfer.通过胎盘转运对抗体糖基化的免疫调节。
Int J Mol Sci. 2023 Nov 26;24(23):16772. doi: 10.3390/ijms242316772.
4
Production of recombinant human IgG1 Fc with beneficial N-glycosylation pattern for anti-inflammatory activity using genome-edited chickens.利用基因编辑鸡生产具有抗炎活性的有益 N-糖型重组人 IgG1 Fc。
Commun Biol. 2023 Jun 1;6(1):589. doi: 10.1038/s42003-023-04937-5.
5
Glycoconjugates: Synthesis, Functional Studies, and Therapeutic Developments.糖缀合物:合成、功能研究与治疗开发。
Chem Rev. 2022 Oct 26;122(20):15603-15671. doi: 10.1021/acs.chemrev.1c01032. Epub 2022 Sep 29.
6
GlycoFibroTyper: A Novel Method for the Glycan Analysis of IgG and the Development of a Biomarker Signature of Liver Fibrosis.糖基纤维分型仪:一种用于 IgG 聚糖分析的新方法和肝纤维化生物标志物特征的建立。
Front Immunol. 2022 Feb 7;13:797460. doi: 10.3389/fimmu.2022.797460. eCollection 2022.
7
Enhanced Immunomodulatory Effect of Intravenous Immunoglobulin by Fc Galactosylation and Nonfucosylation.Fc 半乳糖基化和去岩藻糖化增强静脉注射免疫球蛋白的免疫调节作用。
Front Immunol. 2022 Jan 28;13:818382. doi: 10.3389/fimmu.2022.818382. eCollection 2022.
8
A new approach for identifying positional isomers of glycans cleaved from monoclonal antibodies.一种用于鉴定从单克隆抗体中切割的糖基化位置异构体的新方法。
Analyst. 2021 Jul 26;146(15):4789-4795. doi: 10.1039/d1an00780g.
9
Multiplexed engineering glycosyltransferase genes in CHO cells via targeted integration for producing antibodies with diverse complex-type N-glycans.通过靶向整合在 CHO 细胞中工程化多聚酶糖基转移酶基因,以生产具有多样化复杂型 N-聚糖的抗体。
Sci Rep. 2021 Jun 21;11(1):12969. doi: 10.1038/s41598-021-92320-x.
10
The Possible Role of Anti-Neu5Gc as an Obstacle in Xenotransplantation.抗 Neu5Gc 在异种移植中的可能作用。
Front Immunol. 2020 Apr 15;11:622. doi: 10.3389/fimmu.2020.00622. eCollection 2020.